Colitis associated with docetaxel-based chemotherapy (multiple letters)

Lancet

Volumn 355, Issue 9217, 2000, Pages 1823-1824

  Sezer, O ^a   Eucker, J ^a   Possinger, K ^a   Ibrahim, N K ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; NAVELBINE; PACLITAXEL; TAXANE DERIVATIVE; THIOTEPA;

BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COLITIS; DIGESTIVE SYSTEM ULCER; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTESTINE ISCHEMIA; INTESTINE NECROSIS; INTESTINE PERFORATION; LETTER; MUCOSA INFLAMMATION; NEUTROPENIA; PRIORITY JOURNAL; STOMATITIS;

EID: 0034690664     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)73080-4     Document Type: Letter

References (5)

1. NK Ibrahim AA Sahin RA Dubrow Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer Lancet 355 2000 281 283
2. L Boggio R Pooley SI Roth JN Winter Typhlitis complicating autologous blood stem cell transplantation for breast cancer Bone Marrow Transplant 25 2000 321 326
3. JS Fisherman KH Cowan M Noone Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer J Chn Oncol 14 1996 774 782
4. GM Dosik M Luna M Valdivieso Necrotizing colitis in patients with cancer Am J Med 67 1979 646 656
5. RD Keidan J Fanning RA Gatenby JL Weese Recurrent typhlitis: a disease resulting from aggressive chemotherapy Dis Colon Rectum 32 1989 206 209